Literature DB >> 25350216

Speaking to the deceased child: Australian health professional perspectives in paediatric end-of-life care.

Elizabeth M Forster1, Carol Windsor.   

Abstract

Supporting a dying child and family surrounding the child's death is one of the most significant and challenging roles undertaken by health professionals in paediatric end-of-life care. An Australian study of parent and health-professional constructions of meanings around post-mortem care and communication revealed the practice of health professionals speaking to a child after death. This practice conveyed respect for the personhood of the deceased child, recognised the presence of the deceased child, and assisted in involving parents in their child's post-mortem care. Such findings illuminate an area of end-of-life-care practice that is not often addressed. Talking to a deceased child appeared to be a socially symbolic practice that may promote a continued bond between parent and child.

Entities:  

Keywords:  Bereavement; continuing bonds; end-of-life care; grief; paediatric; parents; post-mortem care

Mesh:

Year:  2014        PMID: 25350216     DOI: 10.12968/ijpn.2014.20.10.502

Source DB:  PubMed          Journal:  Int J Palliat Nurs        ISSN: 1357-6321


  3 in total

1.  Compassionate Design: Utilizing Design Thinking to Preserve Sanctity, Dignity, and Personhood When Children Die.

Authors:  Daniel H Grossoehme; Melissa S Mark; Blake Lane; Allison Rednour; Rachel Thienprayoon
Journal:  Pediatr Qual Saf       Date:  2020-07-08

2.  Communication Coaching: A Case Study of Family Caregiver Burden.

Authors:  Elaine Wittenberg; Betty Ferrell; Marianna Koczywas; Catherine Ferraro
Journal:  Clin J Oncol Nurs       Date:  2017-04-01       Impact factor: 1.283

3.  Metaphors that shape parents' perceptions of effective communication with healthcare practitioners following child death: a qualitative UK study.

Authors:  Sarah Turner; Jeannette Littlemore; Julie Taylor; Eloise Parr; A E Topping
Journal:  BMJ Open       Date:  2022-01-25       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.